Receptor-interacting protein 3 (RIP3) is an essential component of the necroptosis signaling pathway. Phosphorylation of its downstream target, mixed lineage kinase domain-like protein (MLKL), has been proposed to induce necroptosis by initiating Ca 2+ influx. Our previous studies have shown that RGC-5 retinal ganglion cells undergo RIP3-mediated necroptosis following elevated hydrostatic pressure (EHP). However, the molecular mechanism underlying necroptosis induction downstream of RIP3 is still not well understood. Here, we investigated the effects of MLKL during EHP-induced necroptosis, and primarily explored the relationship between MLKL and Ca 2+ influx.
Introduction
Necroptosis, also termed programmed necrosis, has been described as a 'receptor-induced, caspase-independent, highly regulated type of programmed cell death process with morphological resemblance of necrosis' [1, 2] , including loss of integrity of the plasma membrane, organelle swelling, and subsequent loss of intracellular contents.
Previous research has revealed that necroptosis occurs in various models of neural diseases, such as spinal cord injury [3] , hypoxia-ischemiainduced death of cortical neurons [4] , methamphetamine-induced death of cortical neurons [5] , 6-hydroxydopamine-induced death of dopaminergic neurons [6] , and death of retinal ganglion cells (RGCs) following high intraocular pressure (HIOP) [7] [8] [9] , oxygen-glucose deprivation (OGD) [10] , and oxidative stress [11] .
Receptor-interacting protein 3 (RIP3) is regarded as one of the most important molecules involved in regulating necroptosis [12, 13] . When caspases are inhibited, RIP3 and receptor-interacting protein 1 (RIP1) engage in physical and functional interactions to form the necrosome which recruits additional components and ultimately initiates the execution of necroptosis [13] [14] [15] [16] . RIP3 may up-regulate glycogen phosphorylase (PYGL) and glutamine synthase, resulting in hyperphosphorylation of glucose and α-ketoglutarate and subsequent accumulation of reactive oxygen species (ROS), causing mitochondrial dysfunction and necrosis [12] .
Additionally, Sun et al. [17] demonstrated that mixed lineage kinase domain-like protein (MLKL), a pseudokinase with an Nterminal domain for triggering necroptosis and a C-terminal kinaselike domain for inhibitory to MLKL function, is a key mediator of necroptosis signaling downstream of the kinase RIP3. RIP3 phosphorylation and interaction with MLKL lead to the phosphorylation of MLKL during the induction of necroptosis. Further study revealed that after being phosphorylated by RIP3, MLKL undergoes oligomerization and translocation to the plasma membrane, leading to necroptosis [18] [19] [20] [21] . However, the mechanism for the mediation of necroptosis by MLKL via interaction with the plasma membrane is controversial. Previous studies have suggested that MLKL causes necroptosis by targeting downstream cation channels, mediating Ca 2+ [22] or Na + [20] influx and increasing intracellular osmotic pressure, or by directly permeabilizing the plasma membrane [19, 23] . However, further studies are needed to test these models. Our previous studies revealed that RGC-5 necroptosis following elevated hydrostatic pressure (EHP) or OGD is mediated by RIP3 through ROS accumulation [24, 25] . However, our results showed that inhibition of ROS accumulation by the ROS scavenger, butylated hydroxyanisole, could only rescue a portion of the necrotic cells [24] , suggesting that necroptosis may also be induced by ROSindependent pathways. Since MLKL is possibly one of the key mediators of necroptosis downstream of RIP3, we hypothesize that MLKL may play a role in RGC-5 necroptosis induced by EHP.
In the present study, we investigated the possible functions and related mechanisms of MLKL in RGC-5 necroptosis following EHP, and preliminarily explored the relationship between MLKL activity, intracellular Ca 2+ concentration, and Ca 2+ influx following EHP.
Our findings will promote our understanding of the precise regulatory mechanism of RGC necroptosis in acute HIOP-induced retinal diseases and provide experimental evidence to validate potential targets for early intervention in future clinical treatment.
Materials and Methods

Reagents
Rabbit anti-RIP3 antibodies (PRS2283) and propidium iodide (PI) were obtained from Sigma-Aldrich (St Louis, USA). Rabbit anti-RIP3 (phospho S232) antibody (ab195117), rabbit anti-MLKL antibody (N-terminal) (ab194699), and rabbit anti-MLKL (phospho S345) antibody (ab196436) were obtained from Abcam (Cambridge, UK 
Cell culture
Mouse RGC-5 cells were provided by the Department of Ophthalmology, Second Hospital of Jilin University (Changchun, China) [26] . RGC-5 cells were cultured in a medium consisting of Dulbecco's modified Eagle's medium (DMEM; HyClone Laboratories, Inc., Logan, USA), 10% fetal bovine serum (FBS; Gibco, Gaithersburg, USA), 100 U/ml penicillin and 100 μg/ml gentamycin (HyClone Laboratories, Inc.). Cells were maintained in a humidified incubator at 37°C with 5% CO 2 and were used at 2-3 passages post-thawing to minimize variations. 
Cell injury
A pressurized incubator, as described in our previous study [27] , was designed to expose the cells to EHP injury. Cells were exposed in this system for 2 h with a pressure of 100 mmHg and then moved to a conventional culture incubator to recover for different lengths of time (6, 12 , and 24 h). Moreover, an obvious increase of protein level and necrotic cell death was found at 12 h after EHP in this study and our previous study [9, 24] ; thus, this recovery time point was used in the injury groups for subsequent experiments.
Immunofluorescence staining
The coverslips with fixed cells were washed in 0.01 M phosphate buffer saline (PBS) for 5 min, blocked in blocking buffer containing 5% bovine serum albumin (BSA) and 0.3% Triton X-100 for 1 h and subsequently incubated with rabbit anti-MLKL antibody (1:200) at 4°C overnight. Then coverslips were incubated with Cy3-conjugated donkey anti-rabbit secondary antibodies at 1:200 (Jackson Immuno Research Inc., Lancaster, USA) for 2 h at room temperature (RT). After three times wash with PBS, the coverslips were covered with an anti-fading mounting medium with 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, USA) before examination with an Eclipse 80i microscope (Nikon, Tokyo, Japan).
Western blot analysis
At each survival time point, the cell cultures are lysed in a digestion buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 2 mM ethylenediaminetetraacetic acid (EDTA), 1.0% Triton X-100, 1.0% sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS)] containing 1.0% cocktail of protease inhibitors (Cwbiotech, Beijing, China). The cell extracts were incubated at 4°C for 40 min and then centrifuged at 10,000 g for 20 min at 4°C. The supernatants were collected and kept on ice, and then the protein concentration was detected using a bicinchoninic acid assay kit (BCA kit; Cwbiotech). After addition of 4× loading buffer, the supernatant were boiled for 5 min at 100°C. The samples containing 20 μg of total protein were separated on a 10% SDSpolyacrylamide gel by electrophoresis and then transferred onto nitrocellulose membranes (GE Healthcare, Chicago, USA). The membranes was blocked with Tris-buffered saline containing 0.1% Tween 20 (TBS-T) and 5% skim milk (Biosharp, Hefei, China) for 1 h at room temperature and then incubated overnight at 4°C with the following primary antibodies: anti-RIP3 (1:3000), anti-RIP3 (phospho S232) (1:1000), anti-MLKL (1:1500), anti-MLKL (phospho S345) (1:1500) and anti-GAPDH (1:1000) antibodies. After three times of wash with TBS-T for 15 min each, the membranes were incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies (1:20,000; Jackson Immuno Research Inc.) for 2 h at room temperature. The immunoreactive bands are visualized by low or high sensitivity chemiluminescence reagent (Cwbiotech) and images were captured in a Molecular Dynamics Phosphorimager (Nucleo Tech Inc., Rosemont, USA). GAPDH was used as an internal reference control. The integrated density value (IDV) was quantified using Image J (National Institutes of Health, Baltimore, USA).
GSK′872 treatment
GSK′872 is a specific inhibitor of RIP3 [28] [29] [30] [31] . GSK′872 was dissolved in DMSO, and cells were pretreated with 1 or 3 μM of GSK′872 for 1 h before EHP. At the 12 h survival time point, western blot analysis and cellular Ca 2+ overload measurement were carried out.
PI staining
PI staining was used to distinguish necrotic cells from normal ones [8, 9, 32] . PI was dissolved in double distilled water at a concentration of 1 mg/ml as a stock solution. Recovered for 12 h after EHP, the coverslips were washed with PBS for 3 min and then incubated with 10 μg/ml PI-dye solution at 37°C for 15 min. Subsequently, cells were washed in PBS for 3 min before being fixed with 4% paraformaldehyde (PF) for 20 min. After fixation, cells were washed in PBS and then covered with an anti-fading mounting medium with DAPI (Vector Laboratories) before fluorescence microscopy analysis. PI-positive cells were calculated from five fields of each coverslip, and each group contains three pieces of coverslips from three independent experiments. Motic pathology image analysis software (Motic Inc., Xiamen, China) was used to count cells.
LDH release assays
LDH assays are nonradioactive colorimetric assays that measure LDH release from necrotic cells into the extracellular space/supernatant upon rupture of the plasma membrane [33] . After treatment, 96-well plates were centrifuged for 5 min at 400 g and cell-free culture supernatants were collected from each well and incubated with the appropriate reagent mixture according to the manufacturer's instructions at RT for 30 min. The intensity of the red color formed in the assay, measured at a wavelength of 490 nm using an iMark microplate reader (Bio-Rad, Berkeley, USA), was proportional to both LDH activity and the percentage of necrotic cells. Total LDH release was determined in cell cultures treated with LDH-releasing reagent from the assay kit. The percentage of necrotic cell death was calculated based on the color intensity of treated cells minus control cells divided by that of LDH-releasing reagent-treated cells minus control cells from four independent experiments.
Flow cytometry analysis
Cells cultured in the flask were trypsinized and then washed gently with PBS containing 2% BSA. Cells were resuspended in 500 μl binding buffer, and 5 μl of 20 μg/ml Annexin V and 5 μl of 10 μg/ml PI were added to the suspension, and then incubated at RT for 15 min in the dark. Cell death was determined by a FACSCalibur instrument (Becton Dickinson Company, Franklin Lakes, USA). The percentages of cells in each quadrant were analyzed using ModFit software (Verity Software House, Topsham, USA). Statistical analyses of flow cytometry results were conducted by calculating the number of PI-positive cells. All analyses were repeated three times.
Electron microscopy
Cells cultured in the flask were trypsinized and gently washed, and then cells were fixed with 2.5% glutaraldehyde in 0.1 M phosphatebuffered saline at pH 7.4, post-fixed in 1% osmium tetroxide phosphate-buffered saline, and embedded. Ultrathin sections were double stained with uranyl acetate and lead citrate, and then observed under an electron microscope (H-7500; Hitachi, Tokyo, Japan).
SiRNA transfection
SiRNA targeting MLKL had the following sequence: 5′-CCUCUUCCAUGAAGUGAAUdTdT-3′. When the density of RGC-5 cells was around 30%-50%, the transfection was performed with Lipofectamine 2000 according to the manufacturer's protocol. After 4 h of transfection, culture medium is replaced by normal culture medium. Cells were incubated for 24 h after transfection and then trypsinized and collected for further analysis as described above.
Measurement of cellular Ca 2+ overload
Cellular Ca 2+ overload was measured by Ca 2+ concentration using a cell calcium assay kit (Genmed, Shanghai, China) and performed according to the manufacturer's protocol. Cells were harvested and washed twice with ice cold washing reagent, and then the supernatants were collected and kept on ice after lysis, followed by a BCA assay. Serial dilutions of standard reagent (0-0.5 mM) were used to create a standard curve. For analyses, 160 μl of working reagent was added to aliquots of 20 μl of sample or standard in a 96-well plate. The plate was incubated for 5 min at RT, and the absorbance at 595 nm of each well was measured with a microplate reader. The actual Ca 2+ concentration was derived from measured data multiplied by dilution times.
Statistical analysis
All quantitative data were presented as the mean ± standard deviation (SD) from at least three samples per data point. A comparison of groups was performed using one-way analysis of variance (ANOVA). The data were analyzed by using GraphPad Prism 6 (GraphPad Software, La Jolla, USA) and P < 0.05 was set as the threshold of statistical significance.
Results
Immunofluorescence staining of MLKL following EHP
Immunofluorescence staining was used to compare the expression of MLKL in RGC-5 cells at 6, 12, and 24 h after EHP with a control (CTL) group not subject to EHP. Results showed that MLKL was expressed in all groups (Fig. 1) . There was no difference in the fluorescence intensity of MLKL under the microscope at 6 and 24 h after EHP, compared with the control group. However, the fluorescence intensity of MLKL at 12 h after EHP was higher than that in the control group.
Expression levels of RIP3, pRIP3, MLKL, and pMLKL were increased following EHP
Western blotting results revealed the presence of RIP3, phosphorylated RIP3 (pRIP3), MLKL, and phosphorylated MLKL (pMLKL) as a single band in all groups (6, 12 , and 24 h after EHP, and in the control group) ( Fig. 2A) . The RIP3 and pRIP3 bands appeared thicker and larger in the 12 and 24 h groups than those in the control group. The MLKL and pMLKL bands in the 12 h group were significantly more distinct and denser than the bands in the 6 and 24 h groups, which were similar to those in the control group. Statistical analysis of integrated density values (IDVs) indicated that EHP up-regulated the expressions of RIP3, pRIP3, MLKL, and pMLKL shortly after EHP, with significantly higher expressions of these proteins in the 12 h group (Fig. 2B) . These results demonstrated that the protein and phosphorylation levels of RIP3 and MLKL were both increased shortly after EHP, and that the protein and phosphorylation levels of MLKL were subsequently decreased again within one day.
GSK′872 decreased the expression of pMLKL following EHP
To investigate the influence of RIP3 on MLKL phosphorylation, the RIP3-specific inhibitor GSK′872 was added into the RGC-5 culture 1 h before EHP. Western blotting results showed that, after EHP, the MLKL and pMLKL bands in the untreated EHP group and the DMSO-treated EHP group (EHP + DMSO) were thicker and larger than those in the control groups (Fig. 3) . No significant difference in the MLKL bands was observed among the EHP, EHP + DMSO, and GSK′872-treated EHP (EHP + GSK′872) groups. However, the pMLKL bands were thinner and smaller in the group treated with 3 μM GSK′872 than those in the EHP and EHP + DMSO groups. These results indicated that treatment with 3 μM GSK′872 decreased the expression of pMLKL rather than MLKL. 
MLKL protein levels in MLKL-knockdown RGC-5 cells
The relationship between increased MLKL expression and necrotic cell death prompted us to investigate whether MLKL is required for the RGC-5 necroptosis after EHP. The MLKL expression was first knocked down by using siRNA in this study (Fig. 4) . Immunofluorescence staining showed that when RGC-5 cells were treated with siR-NA targeting MLKL, the fluorescence intensity of MLKL and pMLKL was decreased (Fig. 4A) . Western blot analysis demonstrated that both MLKL and pMLKL protein levels were decreased in MLKL-knockdown cells, compared with normal RGC-5 cells, RGC-5 cells transfected with empty vector (Mock), and RGC-5 cells transfected with negative control siRNA (NC) (Fig. 4B) . The IDVs differed significantly among these groups (Fig. 4C) .
EHP-induced RGC-5 cell necroptosis was mediated by MLKL
PI staining of MLKL-knockdown and normal RGC-5 cells was used to confirm the involvement of MLKL in EHP-induced RGC-5 necroptosis after 12 h of recovery (Fig. 5A,B) . PI and DAPI double staining showed that there was no obvious PI fluorescence in the control group, while PI-positive, necrotic cells were observed in the EHP, Mock, and NC groups. When MLKL was knocked down, the number of PI-positive cells was decreased significantly compared with the EHP group. Quantitative analysis of cell necrosis induced by EHP was conducted using LDH release assays (Fig. 5C) . Consistent with the results from PI staining, LDH release assays showed that the viability of RGC-5 cells was significantly reduced in the EHP group compared with the control group, and no difference was found among the EHP, Mock, and NC groups. However, inhibition of MLKL using siRNA reduced RGC-5 cell necrosis by half compared with the EHP group.
Flow cytometry analysis with Annexin V/PI double staining showed that there were more necrotic cells in both the EHP and MLKL-knockdown groups than in the control group (Fig. 6A-C) , and the number of necrotic cells in the MLKL-knockdown group was significantly lower than that in the EHP group (Fig. 6D) . Electron microscopy verified that the RGC-5 cell death observed was indeed necrotic. Unlike the control group, the EHP group showed clear morphological changes characteristic of necrosis, including membrane rupture, cell swelling, and disintegration of organelles (Fig. 6E,F) . Although the number of cells with necrotic morphology in the MLKL-knockdown group seemed lower than in the EHP group based on electron microscopic observation, there were no obvious differences in the morphology of necrotic cells between the EHP group and the MLKL-knockdown group (Fig. 6G) . These results suggest that MLKL-knockdown may protect RGC-5 cells from necrosis following EHP.
Ca
2+ -free treatment attenuated EHP-induced necroptosis
As extracellular Ca 2+ influx has been suggested to play a role in necroptosis [22, 34] , we examined whether Ca 2+ overload is involved in EHP-induced RGC-5 necroptosis by culturing the cells in Ca
2+
-free medium (Fig. 7) . PI staining suggested that the Ca MLKL may be involved in the increase of Ca 2+ level
To further investigate the relationship between MLKL and Ca 2+ overload in EHP-induced RGC-5 necroptosis, the intracellular Ca 2+ concentration was measured. As shown in Fig. 9 , the Ca 2+ concentration was markedly increased in the EHP group as well as in the EHP + DMSO, EHP + Mock, and EHP + NC groups, compared with the control group. Importantly, this increase in Ca 2+ concentration was not observed in MLKL-knockdown cells or GSK′872-treated cells, indicating that increased Ca 2+ influx during necroptosis in RGC-5 cells requires MLKL.
Discussion
Over the past few years, necroptosis has attracted much attention. A growing number of studies have confirmed that ordered activation of RIP1, RIP3, and their downstream substrates is required for the execution of necroptosis [12, 13, 15] . When caspase is inhibited, RIP1 interacts with RIP3 and then either autophosphorylates itself or transphosphorylates RIP3 [35] . Subsequently, RIP3 phosphorylation and activation occur within the assembled necrosome [13, 14, 35, 36] . RIP3 then phosphorylates and activates its functional substrate MLKL [17, 37] , allowing its oligomerization, translocation to the plasma membrane, and permeabilization of the plasma membrane, finally resulting in necroptosis [21, 22, 38, 39] . RIP3 itself is sufficient to initiate the signal transduction cascade resulting in necroptosis. Recent studies have shown that RIP3 initiates necroptosis even in the absence of interaction with RIP1 [40, 41] . In addition, RIP3 deficiency attenuates TNF-α-initiated necroptosis in hippocampal neurons [42] . Kim et al. [43] reported that RIP3 protein level is increased following ischemia-reperfusion injury in rat retina. Moreover, our previous studies demonstrated that RIP3 plays an essential role in RGC necroptosis; RIP3 was significantly upregulated in the rat retina shortly after HIOP [9] , and participated in RGC-5 cell necroptosis following EHP through induction of PYGL activity and subsequent ROS accumulation [24] . However, ROS inhibition could only rescue a portion of the necrotic cells, suggesting the existence of other ROS-independent necroptosis pathways. MLKL is a gateway for the activation of RIP3-dependent necroptosis, and it is directly phosphorylated by RIP3 at Thr357/Ser358 in the activation loop, inducing the release of the N-terminal four-helix bundle domain [23] . However, whether MLKL is involved in RGC-5 cell necroptosis following EHP is largely unknown. In the present study, we found that levels of the unphosphorylated and phosphorylated forms of both RIP3 and MLKL in RGC-5 cells were increased at 12 h after EHP, following a 2 h insult, which coincided with increased necrosis.
Furthermore, RIP3 phosphorylation is believed to induce phosphorylation of the pseudokinase domain of MLKL [17, [44] [45] [46] . However, it is currently unknown whether RIP3 phosphorylation causes MLKL phosphorylation in RGC-5 cells. Our results showed that GSK′872, a specific inhibitor of RIP3, decreased the expression of pMLKL, but not MLKL, indicating that RIP3 may be the upstream regulator of MLKL. In addition, siRNA-mediated silencing of MLKL down-regulated the expressions of both MLKL and pMLKL, possibly because the siRNA decreased the expression of MLKL, reducing the amount available for phosphorylation, as observed in gene silencing experiments on ERK5 [47] . Downregulation of MLKL by siRNA transfection significantly diminished PI uptake and LDH release, indicating decreased necrosis, which was confirmed by flow cytometry and electron microscopy. Collectively, our data suggest that MLKL may participate in EHPinduced necroptosis in RGC-5 cells.
Protein function is commonly studied using gene silencing and specific inhibitors. However, in this study, only siRNA knockdown could be used to study the role of MLKL in EHP-induced RGC-5 necroptosis, because suitable specific inhibitors for mouse MLKL are currently unavailable. Several potential inhibitors of MLKL could be considered, such as necrosulfonamide, Compound 1 (GW806742X), and Compound 4. Necrosulfonamide is a pharmacological inhibitor of human MLKL that binds to the N-terminal domain of MLKL and prevents the necrosome from interacting with its downstream effectors; however, this compound does not target mouse MLKL [17] . Compound 1, previously identified as a nanomolar inhibitor of vascular endothelial growth factor receptor 2 [48] , was recently found also to bind the pseudokinase domain of MLKL, thereby blocking necroptosis induced by tumor necrosis factors, Smac mimetics, and the pan-caspase inhibitor Q-VD-OPh (TSQ) [21] . However, Ma et al. [49] found that Compound 1 not only inhibits MLKL but also non-specifically inhibits the upstream kinase RIP1, which could explain the effect of Compound 1 on necroptosis. Thus, it was not suitable to use this compound as a specific inhibitor of MLKL. They also identified a compound (Compound 4) which binds to MLKL with high selectivity, without binding to RIP1 or RIP3. Unfortunately, this compound is not commercially available.
We were therefore unable to use pharmacological inhibition to probe MLKL function. Current research favors the plasma membrane as the primary site of MLKL action, but the precise mechanisms by which oligomeric MLKL provokes necroptotic plasma membrane permeabilization remain obscure. Cai et al. [22] proposed that MLKL induces Ca 2+ influx, which in turn mediates osmolysis. Other studies revealed that MLKL may regulate Na + influx, thus increasing osmotic pressure [20] , and that MLKL may interact with phospholipids to induce dosedependent liposome leakage [23] . A rise in cytosolic Ca 2+ concentration during necroptosis has also been observed in several studies [50, 51] siRNA. In addition, our results also showed that, to some extent, GSK ′872 treatment inhibits the increase in intracellular Ca 2+ concentration, presumably due to inhibition of MLKL phosphorylation. Therefore, we speculate that MLKL may be the key mediator of necroptosis downstream of RIP3 phosphorylation and it may be involved in Ca 2+ influx during EHP-induced RGC-5 necroptosis.
Xia et al. [52] demonstrated that MLKL forms cation channels that are preferentially permeable to Mg 2+ rather than Ca 2+ . In contrast, Gong et al. [53] recently reported that MLKL activation is necessary and sufficient for Ca 2+ influx, and that Ca 2+ influx appears to participate in the action of ESCRT-III, which is required for formation of plasma membrane 'bubbles' and sustains cell survival when MLKL activation is limited or reversed. Although Gong et al. [53] suggested that Ca 2+ influx is closely related to plasma accumulation can activate other molecules, such as JNK, to induce cell necrosis [51] , and that inhibition of Ca 2+ influx can attenuate necroptosis [22, 51] , indicating that the roles and regulatory mechanisms of MLKL and Ca 2+ influx in necroptosis may not be identical in different injury models or different cell types. Although our study suggests that MLKL may be involved in Ca 2+ influx in EHP-induced RGC-5 necroptosis, additional studies are needed to fully elucidate these mechanisms. EHP. CTL, control group.
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